CA Stock MarketDetailed Quotes

METX ME Therapeutics Holding Inc

Watchlist
  • 7.500
  • 0.0000.00%
15min DelayMarket Closed Feb 26 14:19 ET
221.92MMarket Cap-150.00P/E (TTM)

ME Therapeutics Holding Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-10.91%308.92K
35.72%1.33M
-16.65%324.77K
-1.28%509.86K
310.29%145.07K
475.22%346.76K
624.06%977.37K
389.67K
516.45K
35.36K
Selling and administrative expenses
-14.94%254.62K
11.68%1.06M
-28.15%279.8K
-14.95%418.31K
91.70%63.73K
396.55%299.34K
877.06%950.21K
--389.43K
--491.85K
--33.24K
-General and administrative expense
-14.94%254.62K
11.68%1.06M
-28.15%279.8K
-14.95%418.31K
91.70%63.73K
396.55%299.34K
877.06%950.21K
--389.43K
--491.85K
--33.24K
Research and development costs
-34.50%43.77K
1,050.65%312.02K
19,880.89%44.96K
383.55%118.9K
3,769.12%81.33K
--66.83K
-50.40%27.12K
--225
--24.59K
--2.1K
Depreciation amortization depletion
116,822.22%10.52K
-20.41%39
-25.00%9
-16.67%10
-15.38%11
--9
-19.67%49
--12
--12
--13
-Depreciation and amortization
116,822.22%10.52K
-20.41%39
-25.00%9
-16.67%10
-15.38%11
--9
-19.67%49
--12
--12
--13
Other operating expenses
----
---46.78K
--0
---27.36K
----
---19.42K
----
----
----
----
Operating profit
10.91%-308.92K
-35.72%-1.33M
16.65%-324.77K
1.28%-509.86K
-310.29%-145.07K
-475.22%-346.76K
-624.06%-977.37K
-389.67K
-516.45K
-35.36K
Net non-operating interest income (expenses)
107.24%7.56K
705.70%31.82K
138.55%12.73K
136.21%13.87K
158.19%1.57K
29.11%3.65K
136.56%3.95K
5.34K
5.87K
-2.71K
Non-operating interest income
183.63%10.34K
178.83%31.82K
138.55%12.73K
136.21%13.87K
671.57%1.57K
29.11%3.65K
--11.41K
--5.34K
--5.87K
--204
Non-operating interest expense
--2.79K
--0
--0
--0
--0
--0
-30.91%7.46K
--0
--0
--2.91K
Other net income (expenses)
-5.55M
-2.56M
-2.98M
Special income (charges)
----
--0
--0
--0
----
----
---5.57M
----
----
----
-Less:Restructuring and mergern&acquisition
----
--0
--0
--0
----
----
--5.57M
----
----
----
Other non-operating income (expenses)
----
----
----
----
----
----
--20K
--3M
---2.98M
----
Income before tax
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
-38.06K
Income tax
Earnings from equity interest net of tax
Net income
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
-38.06K
Net income continuous operations
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
---2.95M
---3.49M
---38.06K
Noncontrolling interests
Net income attributable to the company
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
-38.06K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
-38.06K
Diluted earnings per share
0.00%-0.01
81.93%-0.05
92.00%-0.01
86.74%-0.02
-509.01%-0.01
-303.39%-0.01
-4,299.75%-0.2767
-0.1251
-0.1508
-0.0016
Basic earnings per share
0.00%-0.01
81.93%-0.05
92.00%-0.01
86.74%-0.02
-509.01%-0.01
-303.39%-0.01
-4,299.75%-0.2767
-0.1251
-0.1508
-0.0016
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -10.91%308.92K35.72%1.33M-16.65%324.77K-1.28%509.86K310.29%145.07K475.22%346.76K624.06%977.37K389.67K516.45K35.36K
Selling and administrative expenses -14.94%254.62K11.68%1.06M-28.15%279.8K-14.95%418.31K91.70%63.73K396.55%299.34K877.06%950.21K--389.43K--491.85K--33.24K
-General and administrative expense -14.94%254.62K11.68%1.06M-28.15%279.8K-14.95%418.31K91.70%63.73K396.55%299.34K877.06%950.21K--389.43K--491.85K--33.24K
Research and development costs -34.50%43.77K1,050.65%312.02K19,880.89%44.96K383.55%118.9K3,769.12%81.33K--66.83K-50.40%27.12K--225--24.59K--2.1K
Depreciation amortization depletion 116,822.22%10.52K-20.41%39-25.00%9-16.67%10-15.38%11--9-19.67%49--12--12--13
-Depreciation and amortization 116,822.22%10.52K-20.41%39-25.00%9-16.67%10-15.38%11--9-19.67%49--12--12--13
Other operating expenses -------46.78K--0---27.36K-------19.42K----------------
Operating profit 10.91%-308.92K-35.72%-1.33M16.65%-324.77K1.28%-509.86K-310.29%-145.07K-475.22%-346.76K-624.06%-977.37K-389.67K-516.45K-35.36K
Net non-operating interest income (expenses) 107.24%7.56K705.70%31.82K138.55%12.73K136.21%13.87K158.19%1.57K29.11%3.65K136.56%3.95K5.34K5.87K-2.71K
Non-operating interest income 183.63%10.34K178.83%31.82K138.55%12.73K136.21%13.87K671.57%1.57K29.11%3.65K--11.41K--5.34K--5.87K--204
Non-operating interest expense --2.79K--0--0--0--0--0-30.91%7.46K--0--0--2.91K
Other net income (expenses) -5.55M-2.56M-2.98M
Special income (charges) ------0--0--0-----------5.57M------------
-Less:Restructuring and mergern&acquisition ------0--0--0----------5.57M------------
Other non-operating income (expenses) --------------------------20K--3M---2.98M----
Income before tax 12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K-276.99%-143.49K-497.14%-343.11K-4,372.64%-6.52M-2.95M-3.49M-38.06K
Income tax
Earnings from equity interest net of tax
Net income 12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K-276.99%-143.49K-497.14%-343.11K-4,372.64%-6.52M-2.95M-3.49M-38.06K
Net income continuous operations 12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K-276.99%-143.49K-497.14%-343.11K-4,372.64%-6.52M---2.95M---3.49M---38.06K
Noncontrolling interests
Net income attributable to the company 12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K-276.99%-143.49K-497.14%-343.11K-4,372.64%-6.52M-2.95M-3.49M-38.06K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K-276.99%-143.49K-497.14%-343.11K-4,372.64%-6.52M-2.95M-3.49M-38.06K
Diluted earnings per share 0.00%-0.0181.93%-0.0592.00%-0.0186.74%-0.02-509.01%-0.01-303.39%-0.01-4,299.75%-0.2767-0.1251-0.1508-0.0016
Basic earnings per share 0.00%-0.0181.93%-0.0592.00%-0.0186.74%-0.02-509.01%-0.01-303.39%-0.01-4,299.75%-0.2767-0.1251-0.1508-0.0016
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.